CrossrefInfokarte
CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]
OncoTargets and Therapy · 2026-10 · Volume 19 · 1-2
DOI: 10.2147/ott.s665164 ↗Abstract
Kein Abstract verfügbar.
EUVIMED